Mon, November 21, 2022

Yigal Nochomovitz Maintained (ALDX) at Strong Buy with Decreased Target to $23 on, Nov 21st, 2022

Yigal Nochomovitz of Citigroup, Maintained "Aldeyra Therapeutics, Inc." (ALDX) at Strong Buy with Decreased Target from $26 to $23 on, Nov 21st, 2022.

Yigal, nor any peers, have made any analyst calls on ALDX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30